Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Sodium Cholate and Aminophylline Tablets is an oral combination drug product containing sodium cholate, a bile salt, and aminophylline, a methylxanthine bronchodilator. Aminophylline is a 2:1 complex of theophylline and ethylenediamine that acts as a non-selective phosphodiesterase (PDE) inhibitor and adenosine receptor antagonist, resulting in bronchodilation and anti-inflammatory effects. Sodium cholate is included as a bile acid component that may serve as a mucolytic or absorption-enhancing agent. This combination is used in the Chinese clinical setting for respiratory conditions such as bronchial asthma and chronic bronchitis, and it is currently being investigated in a Phase 4 clinical trial for the treatment of mild to moderate acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium cholate + aminophylline.